Empty HPMC Capsules: Market Size & Forecast 2026

The global empty HPMC capsules market sits at approximately USD 1.1 billion in 2025 (base year), growing at a 6.5% CAGR through 2032 to reach roughly USD 1.7 billion. Plant-based and vegetarian positioning is the dominant demand driver, with nutraceutical and pharmaceutical customers shifting systematically away from gelatin capsules on allergen and ethical grounds. Feedstock costs, pharmaceutical-grade hydroxypropyl methylcellulose, account for roughly 60% of finished capsule production cost, tying category economics directly to cellulose-ether pricing and the broader specialty-chemicals cycle. The supply side is structurally concentrated. Three Asia-Pacific-based suppliers, Lonza Capsugel (pending divestiture to Lone Star Funds), ACG, and Shandong Head Group, collectively control an estimated 55-65% of global capacity. Two of these three are investing in US-based manufacturing specific

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.